Page last updated: 2024-08-18

4-butyrolactone and Epithelial Neoplasms

4-butyrolactone has been researched along with Epithelial Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bamodu, OA; Deng, L; Hsiao, M; Huang, CC; Huang, WC; Lee, WH; Lin, YK; Liu, M; Tzeng, YM; Wu, ATH; Yeh, CT; Yuan, CC; Zucha, MA	1
Ahmed, M; Al-Dayel, F; Al-Kuraya, KS; Alyan, A; Bavi, P; Hussain, A; Jehan, Z; Uddin, S	1

Other Studies

2 other study(ies) available for 4-butyrolactone and Epithelial Neoplasms

Article	Year
4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway. Toxicology and applied pharmacology, 2017, 06-15, Volume: 325 Topics: 4-Butyrolactone; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Autophagy-Related Protein 5; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Survival; Cisplatin; Cyclohexanones; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Mice, Inbred NOD; Mice, SCID; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; RNA Interference; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases; Transfection; Tumor Burden; Xenograft Model Antitumor Assays	2017
Overexpression of fatty acid synthase in Middle Eastern epithelial ovarian carcinoma activates AKT and Its inhibition potentiates cisplatin-induced apoptosis. Molecular medicine (Cambridge, Mass.), 2011, Volume: 17, Issue:7-8 Topics: 4-Butyrolactone; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Ovarian Epithelial; Cisplatin; Drug Synergism; Fatty Acid Synthases; Female; Humans; Immunohistochemistry; Mice; Mice, Nude; Middle Aged; Middle East; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Proto-Oncogene Proteins c-akt; RNA Interference; Tissue Array Analysis; Xenograft Model Antitumor Assays; Young Adult	2011

Article

Year

4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.

Toxicology and applied pharmacology, 2017, 06-15, Volume: 325

Topics: 4-Butyrolactone; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Autophagy-Related Protein 5; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Survival; Cisplatin; Cyclohexanones; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Mice, Inbred NOD; Mice, SCID; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; RNA Interference; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases; Transfection; Tumor Burden; Xenograft Model Antitumor Assays

2017

Overexpression of fatty acid synthase in Middle Eastern epithelial ovarian carcinoma activates AKT and Its inhibition potentiates cisplatin-induced apoptosis.

Molecular medicine (Cambridge, Mass.), 2011, Volume: 17, Issue:7-8

Topics: 4-Butyrolactone; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Ovarian Epithelial; Cisplatin; Drug Synergism; Fatty Acid Synthases; Female; Humans; Immunohistochemistry; Mice; Mice, Nude; Middle Aged; Middle East; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Proto-Oncogene Proteins c-akt; RNA Interference; Tissue Array Analysis; Xenograft Model Antitumor Assays; Young Adult

2011